In this issue:
Virological control in panresistant HIV-1 infection
Liver and kidney transplant longterm outcomes in PLWH
Mental illness in PLWH
Intermittent vs continuous ART
Evolocumab effects in PLWH and dyslipidaemia
COVID-19 outcomes in PLWH
Smoking, alcohol and recreational drugs in PLWH
Effectiveness of dolutegravir/rilpivirine 2- and 3-drug regimens
Viral replication, liver fibrosis, and mortality in PLWH + HBV
Efficacy and safety of FTC/TAF versus FTC/TDF in HIV-1
Please login below to download this issue (PDF)